During the webinar, Jarkko discussed the critical role that guidelines and standards play in ensuring the safety and effectiveness of radiotherapy treatments. He shared insights on how MVision AI’s Guideline Based Segmentation solution drives and automates compliance with these guidelines and improves the overall quality of care for patients.
The webinar was presented by Jarkko Niemelä, Co-Founder and CEO of MVision AI. Jarkko is a trained Medical Physicist with over 15 years of experience in the field of radiotherapy. He is passionate about advancing the field through the use of AI and has been instrumental in the development of MVision AI’s innovative #radiotherapy solutions.
